01 January 2003
The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation.
Katarzyna Lietz, Mieczysław Lao, Leszek Paczek, Andrzej Górski, Zbigniew GaciongAnn Transplant 2003; 8(2): 17-24 :: ID: 142807
Abstract
OBJECTIVES: The introduction of recombinant erythropoietin (rHu-EPO) hasbeen shown to reverse anemia of chronic renal failure and was able to almost completely obviate the needfor repeated blood transfusions (BT), the most potent cause of allostimulation in renal transplant candidates.The series describes single center experience of the pretransplant BT and rHu-EPO therapy effects onlate outcomes of cadaveric renal transplantation. METHODS: We retrospectively analyzed data of 502 adultrecipients of primary renal allograft between 1990-1997 whose graft survived > 6 months. In the studygroup 51 patients were treated prior to transplantation with de novo rHu-EPO therapy, 207 patients receivedBT, 184 patients were switched from BT to rHu-EPO therapy, and 60 patients did not require treatment.The groups were compared in respect to pretransplant % PRA, frequency of acute rejections and graft survival.RESULTS: At one-year graft survival was similar between groups, however at five years recipients of denovo rHu-EPO and those who have converted from BT to rHu-EPO experienced only 7% graft loss, as comparedto 22% of patients treated with BT, and 18% of patients who did not require treatment, p < 0.001. Thepretransplant therapy with rHu-EPO was associated with decreased frequency of late episodes of rejectionfrom 0.42 to 0.27, p = 0.03. There were no differences between groups in the number of highly sensitized(PRA > 20%) at the time of transplantation. CONCLUSIONS: The use of rHu-EPO as de novo therapy or conversionfrom BT treatment to rHu-EPO prior to transplantation was associated with a decline in late posttransplantalloreactivity and improved late renal graft survival.
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860